BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37811752)

  • 1. Comparison of Collagenase
    Green B; Flores A; Warner J; Kohler T; Helo S; Trost L
    J Urol; 2023 Nov; 210(5):791-802. PubMed ID: 37811752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
    Alom M; Sharma KL; Toussi A; Kohler T; Trost L
    J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
    Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
    J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
    Levine LA; Larsen SM
    J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes.
    Bajic P; Wiggins AB; Ziegelmann MJ; Levine LA
    J Sex Med; 2020 May; 17(5):1005-1011. PubMed ID: 32127330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
    Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
    J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of collagenase Clostridium histolyticum in men with ventral curvatures: an updated series.
    Larson H; Savage J; Brearton K; Warner R; Ziegelmann M; Kohler T; Trost L
    J Sex Med; 2024 Jan; 21(2):169-174. PubMed ID: 38141054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Collagenase Clostridium histolyticum (Xiapex
    Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N
    Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of RestoreX Penile Traction Therapy in Men With Peyronie's Disease: Results From Open Label and Follow-up Phases.
    Joseph J; Ziegelmann MJ; Alom M; Savage J; Köhler TS; Trost L
    J Sex Med; 2020 Dec; 17(12):2462-2471. PubMed ID: 33223425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
    Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
    J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of collagenase Clostridium histolyticum in men with congenital penile curvature.
    Kulkarni Y; Green B; Pattillo C; Stirland I; Flores A; Ziegelmann M; Kohler T; Helo S; Trost L
    J Sex Med; 2023 Feb; 20(2):194-199. PubMed ID: 36763911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collagenase clostridium histolyticum for Peyronie's disease: A new minimally invasive and effective treatment].
    Lin HC; Zhang HT; Jiang H
    Zhonghua Nan Ke Xue; 2017 Sep; 23(9):771-775. PubMed ID: 29726655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.
    Ziegelmann M; Savage J; Toussi A; Alom M; Yang D; Kohler T; Trost L
    J Urol; 2019 Sep; 202(3):599-610. PubMed ID: 30916626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment.
    Wymer K; Kohler T; Trost L
    J Sex Med; 2019 Sep; 16(9):1421-1432. PubMed ID: 31351851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
    Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
    J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Comparison of Collagenase
    Desouky E; Levine LA
    J Urol; 2024 May; 211(5):708-709. PubMed ID: 38382016
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.
    Fernández-Pascual E; González-García FJ; Angulo J; Cerezo E; Quintana LM; Turo J; Martínez-Ballesteros C; Carballido J; Martínez-Salamanca JI
    BJU Int; 2019 Dec; 124(6):1055-1062. PubMed ID: 31033130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
    Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
    J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
    Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
    J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
    Sukumar S; Pijush DB; Brandes S
    J Sex Med; 2020 Jan; 17(1):111-116. PubMed ID: 31759930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.